Compliance

No Sex Please, We’re British: More from GSK in China

No Sex Please, We’re British: More from GSK in China

The GSK China scandal came to light through a sex tape, and the anonymous whistleblower who leaked the tape also presented allegations of bribery. GSK's own investigation into the matter has failed to net anything of substance, but the Chinese government has turned up a great deal of evidence pointing to massive systemic bribery.

Winning the War Against Conflict Minerals

Winning the War Against Conflict Minerals

Recent legislation has had a significant impact on the trade of conflict minerals, including "blood diamonds," out of areas ravaged by war and run by warlords. The deadline for reporting supply chain partners, per Dodd-Frank, has come and gone, and companies have found it difficult to say with certainty whether their materials are truly conflict-free. A QMS can be hugely...

In Due Diligence and World Cup Bids: Follow the Money

In Due Diligence and World Cup Bids: Follow the Money

In the past month, we've heard plenty of allegations of corruption associated with the Brazil World Cup, but there's as much or more controversy surrounding the forthcoming events in Qatar. Tom Fox suggests that when there's a question of corruption, just follow the money. And in this case, it's flying in all sorts of questionable directions.

Tips to Keep the DEA Away

Tips to Keep the DEA Away

Independent pharmacies have their work cut out for them when it comes to remaining compliant with ever-changing industry regulations. The mom and pop shops known for their personal service are subject to the same standards as their big-box counterparts. Here’s a rundown of DEA red flags and preventive measures to avoid violations.

Antitrust and Competition: Understanding the Risks

Antitrust and Competition: Understanding the Risks

An in-depth look at antitrust activity and litigation over the past several years, with keen insight into what’s to come. Effective compliance programs are vital, without a doubt. But if your organization is faced with an antitrust violation, don’t expect leniency from the Federal Trade Commission and Department of Justice on those grounds.

Rationalizing Bribery: Corruption Has No Witness

Rationalizing Bribery: Corruption Has No Witness

When there’s no witness to wrongdoing, it can be so much easier to justify. And there are rarely witnesses when bribes are being made. The situation gets particularly sticky when compensation is a factor; the internal discussion turns from “do I need to report this” to “what would reporting this cost me?”

The Light at the End of the Tunnel . . . or Cliff

The Light at the End of the Tunnel . . . or Cliff

A few months into its fifth year, the Affordable Care Act remains true to its original set of goals and does not appear to be losing its momentum in its quest to reform health care. Author Craig Garner provides expert analysis of the order's impact on the industry -- and some forecasts for what's to come.

Page 103 of 109 1 102 103 104 109